Gem Aromatics Ltd (GEMAROMA) — concall transcript | 30 June 2026

Gem Aromatics reported Q1 FY27 consolidated revenue of INR99 crores with 16.7% gross margins and a INR7.9 crore loss driven by Dahej capex depreciation. Management highlighted progress in new product verticals — cooling agents, Safranal, and phenol derivatives — with revenue expected from Q3 FY27. Madagascar supply chain disruptions are resolved, and customer approvals for new products are advancing. Capex of INR270 crores supports Krystal Ingredients expansion, targeting 25% utilization by Q3 FY27. Margin recovery hinges on value-added products and scale. Forward guidance points to meaningful revenue contributions in FY28, with restocking demand expected to boost Q1 FY27 performance.